Cancer Survivorship SpecialistsPage 26

Ikumi Suzuki, M.D.

Assistant Professor of Medicine

Oncology

Aparna Parikh, M.D.

Oncology

Kerry Reynolds, MD

Assistant Professor of Medicine, Harvard Medical School; Clinical Director, Inpatient Oncology, Massachusetts General Hospital; Director, Severe Immunotherapy Complications Service, Mass General Brigham

Oncology

Dulabh Monga, MD

Associate Professor of Medicine, Drexel University College of Medicine; Lead, Pancreas Cancer Disease Site Leadership Program, AHN

Oncology

Adam Sperling, M.D.,PH.D.

Director of Basic and Correlative Science, Multiple Myeloma and Cell Therapies; Assistant Professor of Medicine, Harvard Medical School

Oncology

Anand Karnad, M.D.

Chief, Division of Hematology-Oncology

Oncology

Jennifer Temel, MD

Professor of Medicine at Harvard Medical School, Clinical Director of Thoracic Oncology at Massachusetts General Hospital, Co-Director of the Cancer Outcomes Research and Education Program at Massachusetts General Hospital Cancer Center

Oncology

Stanley Waintraub, MD

Oncology

Patrick Grierson, MD

Assistant Professor, Medical Oncology

Oncology

Peter Westervelt, MD

MD, PhD

Oncology

Roger Pearse, MD

Oncology

Keith Stockerl-Goldstein, MD

Professor, Oncology, Washington University School of Medicine

Oncology

Jia Luo, MD

Assistant Professor of Medicine, Harvard Medical School; Chief Resident in Internal Medicine

Oncology

Philip Gold, MD

Director of Clinical Research and Program Leader, Gastrointestinal Oncology Program, Swedish Cancer Institute

Oncology

David Lovett, MD

Oncology

Michael Slade, MD

Assistant Professor of Medicine, Division of Oncology

Oncology

Antonio Jimeno, MD

Clinical Leader, Head and Neck Clinical Program

Oncology

Ethan Basch, MD

Richard M. Goldberg Distinguished Professor of Medicine; Chief, Division of Oncology; Physician-in-Chief, North Carolina Basnight Cancer Hospital

Oncology

Kelly Paulson, MD, PHD

Director, Center for Immuno-Oncology

Oncology

Josephine Taverna, M.D.

Associate Professor, Division of Hematology Oncology and Department of Molecular Medicine, University of Texas Health Science Center San Antonio

Oncology